![Eagle Pharmaceuticals Inc](/common/images/company/N_EGRX.png)
Eagle Pharmaceuticals Inc (EGRX)
NASDAQ
Quarter End | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 39.85M | 42.32M | 115.87M | 74.14M | 65.9M | 60.7M | 66.31M | 64.65M |
Operating Income | -10.18M | 5.9M | 59.83M | 503k | 9.46M | -2.93M | 11.77M | 10.3M |
Pre Tax Income | -12.66M | 1.22M | 57.66M | -5.87M | -3.66M | 13.3M | 10.23M | 9.3M |
Net Income | -5.62M | -6.2M | 44.06M | -9.45M | -7.13M | 8.17M | 5.75M | 5.16M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -11.97M | 1.45M | 57.87M | -7.26M | -2.12M | 2.61M | 11.54M | 10.31M |
EBITDA | -9.27M | 6.97M | 60.74M | 2.14M | 13.31M | 2.7M | 17.33M | 15.88M |
Year End December 30 2022 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 66.23M | 189.48M | 236.71M | 213.31M | 195.89M | 187.8M | 171.55M | 316.61M |
Operating Income | 2.56M | 51.6M | 68.26M | 38.56M | 21.82M | 32.95M | 2.77M | 80.96M |
Pre Tax Income | 2.57M | 53.43M | 72.95M | 34.04M | 22M | 22.68M | -4.55M | 61.43M |
Net Income | 2.57M | 81.45M | 51.94M | 31.9M | 14.31M | 11.99M | -8.63M | 35.64M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0.164 | 5.315 | 3.498 | 1.933 | 1.05 | 0.918 | -0.674 | 2.738 |
EBIT | 2.56M | 53.35M | 73.99M | 38.56M | 22.52M | 24.69M | -3.47M | 65.21M |
EBITDA | 2.67M | 53.19M | 79.25M | 42.23M | 25.31M | 36.53M | 6.53M | 92.98M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.